Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Expert Review of Pharmacoeconomics & Outcomes Research|July 16, 2015
Use of quality checklists and need for disease-specific guidance in economic evaluations: a meta-reviewGerardus Wj Frederix, Johan L Severens, Anke M Hövels
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 7, 2019
Accuracy of budget impact estimations and impact on patient access: a hepatitis C case studyJoost W Geenen, Cornelis Boersma, Olaf H Klungel, et al.
Journal of Market Access & Health Policy|December 17, 2019
Affordability of oncology drugs: accuracy of budget impact estimationsJoost W Geenen, Mark Jut, Cornelis Boersma, et al.
Plos One|May 10, 2018
Disparities in model-based cost-effectiveness analyses of tuberculosis diagnosis: A systematic reviewT I Armina Padmasawitri, Gerardus W Frederix, Bachti Alisjahbana, et al.
Research in Social & Administrative Pharmacy : RSAP|November 16, 2018
How community pharmacists prioritize cognitive pharmaceutical servicesJeroen M van de Pol, Ellen S Koster, Anke M Hövels, et al.
Vaccine|January 25, 2008
The cost-utility of rotavirus vaccination with Rotarix (RIX4414) in the NetherlandsLucas M A Goossens, Baudouin Standaert, Nico Hartwig, et al.
Pharmacoeconomics - Open|July 13, 2019
Managing Uncertainties Due to Limited Evidence in Economic Evaluations of Novel Anti-Tuberculosis Regimens: A Systematic ReviewT I Armina Padmasawitri, Sarah Maria Saragih, Gerardus W Frederix, et al.
European Radiology|July 14, 2004
Cost-analysis of staging methods for lymph nodes in patients with prostate cancer: MRI with a lymph node-specific contrast agent compared to pelvic lymph node dissection or CTAnke M Hövels, Roel A M Heesakkers, Eddy M Adang, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 19, 2020
Differences in Health Technology Assessment Recommendations Among European Jurisdictions: The Role of Practice VariationsRick A Vreman, Aukje K Mantel-Teeuwisse, Anke M Hövels, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 18, 2015
[Threshold value for reimbursement of costs of new drugs: cost-effectiveness research and modelling are essential links]Geert W J Frederix, Anke M Hövels, Johan L Severens, et al.
Pageof 4